SEC INSIDER TRANSACTIONS

Reddit, Inc. (RDDT) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

RDDT · Reddit, Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 52 filings · fetched 2026-11-13T19:39:18Z

Recent reported activity

0purchase rows on this page

16sale rows on this page

221matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F16	M Exercise / conversionStock Option (Right to Buy) · Derivative	39,167D	0	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F15	S Sale (market/private)Class A Common Stock · Non-derivative	200D	206.83	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F14	S Sale (market/private)Class A Common Stock · Non-derivative	500D	205.85	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F13	S Sale (market/private)Class A Common Stock · Non-derivative	100D	204.14	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F12	S Sale (market/private)Class A Common Stock · Non-derivative	700D	201.94	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F11	S Sale (market/private)Class A Common Stock · Non-derivative	3,616D	200.89	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F10	S Sale (market/private)Class A Common Stock · Non-derivative	3,184D	199.89	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F9	S Sale (market/private)Class A Common Stock · Non-derivative	4,900D	198.94	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F8	S Sale (market/private)Class A Common Stock · Non-derivative	10,767D	198.03	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F7	S Sale (market/private)Class A Common Stock · Non-derivative	5,600D	196.83	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F6	S Sale (market/private)Class A Common Stock · Non-derivative	4,047D	195.79	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F5	S Sale (market/private)Class A Common Stock · Non-derivative	4,053D	195.1	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F4	S Sale (market/private)Class A Common Stock · Non-derivative	700D	193.85	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F3	S Sale (market/private)Class A Common Stock · Non-derivative	500D	192.08	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1, F2	S Sale (market/private)Class A Common Stock · Non-derivative	300D	190.54	Direct	Form 4 ↗0001663651-26-000015
2026-07-15Filed 2026-07-17	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025. F2 The sales were executed in multiple trades at prices ranging from $190.38 to $190.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 15 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $191.54 to $192.49. F4 The sales were executed in multiple trades at prices ranging from $193.39 to $194.19. F5 The sales were executed in multiple trades at prices ranging from $194.39 to $195.37. F6 The sales were executed in multiple trades at prices ranging from $195.39 to $196.35. F7 The sales were executed in multiple trades at prices ranging from $196.39 to $197.34. F8 The sales were executed in multiple trades at prices ranging from $197.48 to $198.46. F9 The sales were executed in multiple trades at prices ranging from $198.48 to $199.47. F10 The sales were executed in multiple trades at prices ranging from $199.48 to $200.46. F11 The sales were executed in multiple trades at prices ranging from $200.49 to $201.47. F12 The sales were executed in multiple trades at prices ranging from $201.50 to $202.22. F13 The sales were executed in multiple trades at prices ranging from $204.13 to $204.14. F14 The sales were executed in multiple trades at prices ranging from $205.69 to $206.51. F15 The sales were executed in multiple trades at prices ranging from $206.80 to $206.85. F16 The stock option is fully vested and currently exercisable. References: F1	M Exercise / conversionClass A Common Stock · Non-derivative	39,167A	5.35	Direct	Form 4 ↗0001663651-26-000015
2026-07-05Filed 2026-07-07	Gale Mary PorterDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantClass A Common Stock · Non-derivative	107A	0	Direct	Form 4 ↗0001924581-26-000005
2026-07-05Filed 2026-07-07	Newhouse Steven ODirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The shares are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"), or (ii) as otherwise provided by the Program. F2 Advance Magazine Publishers Inc., a New York corporation ("AMPI"), owns the securities of the Company set forth on this report. Mr. Newhouse, by virtue of his affiliations with Advance Publications, Inc. a New York corporation ("API"), and certain holders of equity in API, may be deemed to beneficially own the securities of the Company owned directly by AMPI. API is the indirect parent company of AMPI. F3 Mr. Newhouse disclaims beneficial ownership of the securities owned by AMPI, and this report shall not be deemed an admission that Mr. Newhouse is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. References: F1	A Award / grantClass A common stock, par value $0.0001 per share · Non-derivative	115A	0	Direct	Form 4 ↗0001913168-26-000005
2026-07-05Filed 2026-07-07	Seibel MichaelDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantClass A Common Stock · Non-derivative	103A	0	Direct	Form 4 ↗0001835628-26-000008
2026-07-05Filed 2026-07-07	FARRELL SARAH EDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Waygrove Partnership LP., a Delaware limited partnership ("Waygrove"), owns the securities of the Company set forth on this report. Ms. Farrell, by virtue of her affiliation with Waygrove, may be deemed to beneficially own the securities of the Company owned directly by Waygrove. Ms. Farrell disclaims beneficial ownership of the securities owned by Waygrove, and this report shall not be deemed an admission that Ms. Farrell is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. References:	A Award / grantClass A Common Stock · Non-derivative	126A	0	Direct	Form 4 ↗0001808740-26-000008
2026-07-05Filed 2026-07-07	Habiger David CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantClass A Common Stock · Non-derivative	283A	0	Direct	Form 4 ↗0001326409-26-000005
2026-07-05Filed 2026-07-07	FILIKRUSHEL PATRICIADirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The shares are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"), or (ii) as otherwise provided by the Program. References: F1	A Award / grantClass A Common Stock · Non-derivative	122A	0	Direct	Form 4 ↗0001237450-26-000006
2026-07-01Filed 2026-07-06	Reynolds Michelle MarieOfficer · Chief Accounting Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. References: F1	S Sale (market/private)Class A Common Stock · Non-derivative	808D	200	Direct	Form 4 ↗0001713445-26-000093
2026-06-30Filed 2026-07-02	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025. F2 The sales were executed in multiple trades at prices ranging from $170.27 to $171.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 6 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $171.29 to $172.27. F4 The sales were executed in multiple trades at prices ranging from $172.33 to $173.31. F5 The sales were executed in multiple trades at prices ranging from $173.36 to $174.33. F6 The sales were executed in multiple trades at prices ranging from $174.38 to $174.83. F7 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F8 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F8	M Exercise / conversionStock Option (Right to Buy) · Derivative	18,000D	0	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001713445-26-000092
2026-06-30Filed 2026-07-02	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025. F2 The sales were executed in multiple trades at prices ranging from $170.27 to $171.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 6 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $171.29 to $172.27. F4 The sales were executed in multiple trades at prices ranging from $172.33 to $173.31. F5 The sales were executed in multiple trades at prices ranging from $173.36 to $174.33. F6 The sales were executed in multiple trades at prices ranging from $174.38 to $174.83. F7 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F8 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F6	S Sale (market/private)Class A Common Stock · Non-derivative	800D	174.61	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001713445-26-000092

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.